Scientists Design Bacteria to Reflect 'Sonar' Signals for Ultrasound Imaging

In the 1966 science fiction film Fantastic Voyage, a submarine is shrunken down and injected into a scientist's body to repair a blood clot in his brain. While the movie may be still be fiction, researchers at Caltech are making strides in this direction: they have, for the first time, created bacterial cells with the ability to reflect sound waves, reminiscent of how submarines reflect sonar to reveal their locations.

The ultimate goal is to be able to inject therapeutic bacteria into a patient's body - for example, as probiotics to help treat diseases of the gut or as targeted tumor treatments - and then use ultrasound machines to hit the engineered bacteria with sound waves to generate images that reveal the locations of the microbes. The pictures would let doctors know if the treatments made it to the right place in the body and were working properly.

"We are engineering the bacterial cells so they can bounce sound waves back to us and let us know their location the way a ship or submarine scatters sonar when another ship is looking for it," says Mikhail Shapiro, assistant professor of chemical engineering, Schlinger Scholar, and Heritage Medical Research Institute Investigator. "We want to be able to ask the bacteria, 'Where are you and how are you doing?' The first step is to learn to visualize and locate the cells, and the next step is to communicate with them."

The results will be published in the January 4 issue of the journal Nature. The lead author is Raymond Bourdeau, a former postdoctoral scholar in Shapiro's lab.

The idea of using bacteria as medicine is not new. Probiotics have been developed to treat conditions of the gut, such as irritable bowel disease, and some early studies have shown that bacteria can be used to target and destroy cancer cells. But visualizing these bacterial cells as well as communicating with them - both to gather intel on what's happening in the body and give the bacteria instructions about what to do next - is not yet possible. Imaging techniques that rely on light - such as taking pictures of cells tagged with a "reporter gene" that codes for green fluorescent protein - only work in tissue samples removed from the body. This is because light cannot penetrate into deeper tissues like the gut, where the bacterial cells would reside.

Shapiro wants to solve this problem with ultrasound techniques because sound waves can travel deeper into bodies. He says he had a eureka moment about six years ago when he learned about gas-filled protein structures in water-dwelling bacteria that help regulate the organisms' buoyancy. Shapiro hypothesized that these structures, called gas vesicles, could bounce back sound waves in ways that make them distinguishable from other types of cells. Indeed, Shapiro and his colleagues demonstrated that the gas vesicles can be imaged with ultrasound in the guts and other tissues of mice.

The team's next goal was to transfer the genes for making gas vesicles from the water-dwelling bacteria into a different type of bacteria - Escherichia coli, which is commonly used in microbial therapeutics, such as probiotics.

"We wanted to teach the E. coli bacteria to make the gas vesicles themselves," says Shapiro. "I've been wanting to do this ever since we realized the potential of gas vesicles, but we hit some roadblocks along the way. When we finally got the system to work, we were ecstatic."

One of the challenges the team hit involved the transfer of the genetic machinery for gas vesicles into E. coli. They first tried to transfer gas-vesicle genes isolated from a water-dwelling bacterium called Anabaena flos-aquae, but this didn't work - the E. coli failed to make the vesicles. They tried again using gas-vesicle genes from a closer relative of E. coli, a bacterium called Bacillus megaterium. This didn't succeed either, because the resulting gas vesicles were too small to efficiently scatter sound waves. Finally, the team tried a mix of genes from both species - and it worked. The E. coli made gas vesicles on their own.

The gas vesicle genes code for proteins that act like either bricks or cranes in building the final vesicle structure - some of the proteins are the building blocks of the vesicles while some help in actually assembling the structures. "Essentially, we figured out that we need the bricks from Anabaena flos-aquae and the cranes from Bacillus megaterium in order for the E. coli to be able to make gas vesicles," says Bourdeau.

Subsequent experiments from the team demonstrated that the engineered E. coli could indeed be imaged and located within the guts of mice using ultrasound.

"This is the first acoustic reporter gene for use in ultrasound imaging," says Shapiro. "We hope it will ultimately do for ultrasound what green fluorescent protein has done for light-based imaging techniques, which is to really revolutionize the imaging of cells in ways there were not possible before."

The researchers say the technology should be available soon to scientists who do research in animals, although it will take many more years to develop the method for use in humans.

Raymond W Bourdeau, Audrey Lee-Gosselin, Anupama Lakshmanan, Arash Farhadi, Sripriya Ravindra Kumar, Suchita P Nety, Mikhail G. Shapiro.
Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts.
Nature 553, 86–90. doi: 10.1038/nature25021.

Most Popular Now

Open Call SC1-DTH-01-2019: Big Data and …

Currently available methods and strategies for diagnosis and treatment of cancer help clinicians continuously improve quality of care and prevent cancer deaths in the population. Accurate risk assessment, availability of...

Cerner Selected for NHS Framework to Sup…

Integrated Care Systems (ICS) and Sustainability and Transformation Partnerships (STPs) aim to deliver the best possible quality of health and care, shift to value-based care and proactively improve outcomes for...

Brainlab and Magic Leap Partner in Digit…

Brainlab has announced a strategic development partnership with Florida-based Magic Leap, a developer of proprietary spatial computing solutions that help users enrich their real world experience by integrating digital content...

The Merck Accelerator Program 2019

The Merck Accelerator is looking for real partners so that you can work together in shaping the future. With programs in the headquarters in Germany, in China and the Satellites...

Whole-Brain Connectome Maps Teach Artifi…

Medical University of South Carolina (MUSC) neurologists have developed a new method based on artificial intelligence that may eventually help both patients and doctors weigh the pros and cons of...

Oxehealth Secures World-First Accreditat…

The British Standards Institute (BSI) has accredited Oxehealth's vital signs measurement software as a Class IIa medical device in Europe. This is the first time that software enabling a digital...

MEDICA 2018: The Starting Block for Many…

12 - 15 November 2018, Düsseldorf, Germany. MEDICA, the world’s leading medical trade fair in Düsseldorf which attracts over 5,000 exhibitors from around 70 countries, is becoming an even bigger hotspot...

MEDICA 2018 Presents the Future of Medic…

12 - 15 November 2018, Düsseldorf, Germany. Artificial intelligence, Big Data or IoT (Internet of Things) - we would be hard pressed to find a sector that doesn’t have these terms...

Artificial Intelligence for Health: ITU …

The ITU Focus Group on 'AI for Health' (FG-AI4H), created in collaboration with the World Health Organization (WHO), has issued a Call for Proposals to identify compelling use cases of...

Siemens Healthineers and STORZ MEDICAL P…

On the occasion of the 70th annual congress of the German Society for Urology, DGU, Siemens Healthineers and STORZ MEDICAL have announced plans to enter into a sales partnership agreement...

Spinal Cord Stimulation, Physical Therap…

Spinal cord stimulation and physical therapy have helped a man paralyzed since 2013 regain his ability to stand and walk with assistance. The results, achieved in a research collaboration between...

Sandoz Healthcare Access Challenge #Sand…

Sandoz, the Novartis generics and biosimilars division, today announces the launch of the second Sandoz Healthcare Access Challenge (HACk). The #SandozHACk is a global competition that invites entrepreneurs and innovators...